Recent Progress on the Molecular Aspects of Endocrine Tumors: Clinical Implications

Hormone Research in Paediatrics

Volumn 47, Issue 4-6, 1997, Pages 227-234

  Barlier, A B ^a,b   Pellegrini Bouiller, I P ^a   Caccavelli, L ^a   Gunz, G ^a   Morange Ramos, I M ^a,b   Jaquet, P J ^a,b   Enjalbert, A ^a  

^a Laboratoire ICNE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Bromocriptine resistance; D2 receptor; Gsponcogene; Pathogenesis; Pituitary adenomas; Transduction signal

Indexed keywords

ADENYLATE CYCLASE; BROMOCRIPTINE; CYCLIC AMP; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE RECEPTOR; MESSENGER RNA; ONCOPROTEIN; PROLACTIN; TRANSCRIPTION FACTOR PIT 1;

ALTERNATIVE RNA SPLICING; BINDING SITE; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; DRUG RESISTANCE; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HYPOPHYSIS ADENOMA; ONCOGENE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTINOMA; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR VOLUME;

ADENOMA; GTP-BINDING PROTEINS; HUMANS; PITUITARY NEOPLASMS; POINT MUTATION; PROLACTINOMA; SIGNAL TRANSDUCTION;

EID: 0031003155     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185468     Document Type: Article

References (61)

1. Molitch ME: Pathogenesis of pituitary tumors, Endocrinol Mctab Clin 1987:16:503-527.
2. Davis JRE, Hoggard N: Towards the pathogenesis of human pituitary tumours, J Endocrinol 1993;136:3-6.
3. Levy A, Lightman SL: The pathogenesis of pituitary adenomas, Clin Endocrinol 1993:38: 559-570.
4. Melmed S: Pathogenesis of pituitary tumors; in Levine AJ, Schmidek HM (cds): Molecular genetics of nervous system tumors, Chichester, Wiley-Liss, 1993, pp 255-263.
5. Morange-Ramos I, Pellegrini I, C'accavclli L, Brue T, Enjalbcrt A, Jaquet P: Etiopathogenie des tumeurs hypophysaires, Ann Endocrinol (Paris) 1994:55:25-32.
6. Mayo KE, I lammer RE, Swanson LW, Bnnster RL, Roscnfeld MG, Evans RM: Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene, Mol Endocrinol 1988;2:606-612.
7. Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinsky NE, Billestrup N, Price J, Vale W: Adenohypophysial changes in mice transgenic for human growth hormone releasing factor, Endocrinology 1989:125:2710-2718.
8. Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W: Pituitary adenomas in mice transgenic for growth hormone-releasing hormone, Endocrinology 1992:131:2083-2089.
9. Asa SL, Scheithauer BW, Bilbao JM, Horvath E, Ryan N, Kovacs K, Randall RV, Laws ER, Singer W, Linfoot JA, Thomer MO, Vale W: A case for hypothalamic acromegaly: A clinico-pathological study of 6 patients with hypothalamic gangliocvtomas producing growth hormone releasing factor, J Clin Endocrinol Mctab 1984:58:796-803.
10. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S: Clonal origin of pituitary adenomas, J Clin Endocrinol Metab 1990:71:1427-1433.
11. Gicquel C, Lc Bouc Y, Luton JP, Girard F, Ber-tagna X: Monoclonality of corticotroph ma-croadcnomas in Cushing's disease, J Clin Endocrinol Metab 1992;75:472-475.
12. Vallar L, Spada A, Giannatasio G: Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature 1987; 330:566-568.
13. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the u chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature 1989:340:692-696.
14. Billestrup N, Mitchell RL, Vale W, Vcrma IM: Growth hormone-releasing factor induces c-fos expression in cultured pituitary cells, Mol Endocrinol 1987;1:300-305.
15. Billestrup N, Swanson LW, Vale W: Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro, Proc Natl Acad Sci USA 1986:83:6854-6857.
16. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Dull QY, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumours, Science 1990;249:655-659.
17. Tordjman K, Stern N, Ouakinc G, Yossiphov Y, Razon N, Nordcnskjold M, Friedman E: Activating mutations of the Gs-u gene in nonfunctioning pituitary tumors, J Clin Endocrinol Metab 1993:77:765-769.
18. Williamsom EA, Daniels M, Foster S, Kelly WF, Kcndall-Taylor P, Harris PE: Gsa and Gi2a mutations in clinically non-functioning pituitary tumours, Clin Endocrinol 1994,41: 815-820.
19. Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassctti M, Faglia G: Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclasc, J Clin Endocrinol Metab 1990;71:1421-1426.
20. Adams EF, Lei T, Buchfelder M, Petersen B, Fahlbusch R: Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies, J Clin Endocrinol Metab 1995:80: 2077-2081.
21. Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR: Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein, J Clin Endocrinol Mctab 1990:71:1416-1420.
22. Hashimoto K, Koga M, Motomura T, Kasava-ma S, Kouhara H, Ohnishi T, Arita N, Hayaka-ma T, Sato B, Kishomoto T: Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas, J Clin Endocrinol Metab 1995:80: 2933-2939.
23. Pei C, Melmed S, Scheithauer B, Kovacs K, Prager D: H-ras mutations in human pituitary carcinoma metastases, J Clin Endocrinol Mctab 1994:77:50-55.
24. Karga HJ, Alexander JM, Hedley-White ET, Klibanski A, Jameson JL: Ras mutation in human pituitary tumors, J Clin Endocrinol Mctab 1992;74:914-919.
25. McCormick F: Ras oncogenes: in Weinberg RA (cd): Oncogenes and the Molecular Origins of Cancer, Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989, pp 125-145.
26. Alvaro V, Touraine P, Raisman-Vozari RR, Bai-Grenicr F, Birman P, Joubert D: Protein kinase C activity and expression in normal and adenomatous human pituitaries, Int J Cancer 1992;50:724-730.
27. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Queyrat B, Joubert D: Invasive human pituitary tumor express a point mutated u-protein kinase C, J Clin Endocrinol Metab 1993:77; 1125-1129.
28. Thapar K, Kalman K, Laws ER, Muller PJ: Pituitary adenomas: Current concepts in classification, histopathologvand molecular biology, Endocrinologist 1993;3:39-57.
29. Enjalbcrt A, Bockaert J: Pharmacological characterization of the D2 dopamine receptor negatively couplcd with adenylate cyclase in rat anterior pituitary, Mol Pharmacol 1983:23: 576-584.
30. Caccavclli L, Cussac D, Pellegrini I, Audinot V, Jaquet P, Enjalbert A: D2 dopaminergic receptors: Normal and abnormal transduction mechanisms, Horm Res 1992:38:78—83.
31. De Camilli P, Macconi D, Spada A: Dopamine inhibits adenylate cyclasc in human prolactin secreting pituitary adenomas, Nature 1979: 278:252-254.
32. 3]-Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone and adrenocorticotropic hormone, J Clin Endocrinol Metab 1979;50:387-391.
33. Bression D, Brandi AM, Martres MP, Nous-baum A, Cesselin F, Racadot J, Peillon F: Dopaminergic receptor in human prolactin-secreting adenomas: A quantitative study, J Clin Endocrinol Metab 1980;51:1037-1043.
34. Pellegrini I, Gunz G, Grisoli F, Jaquet P: Abnormal dopamine sensitivity in some human prolactinomas, Horm Res 1989;31:19-23.
35. Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Dclivet S, Jedynak CY, Kordon C, Peillon F, Jaquet P, Enjalbert A: Resistance to bromocriptine in human prolactinomas, J Clin Endocrinol Mctab 1989:69:500-509.
36. Pellegrini-Bouiller I, Morange-Ramos I, Barlier A, Gunz G, Figarella-Branger D, Cortct-Rudelli C, Grisoli F, Jaquet P, Enjalbert A: Pit-1 gene expression in human lactotroph and somatotroph pituitary' adenomas is correlated to D2 receptor gene expression, J Clin Endocrinol Metab 1996;81:3390-3396.
37. Brue T, Caccavclli L, Morange I, Pellegrini I, Jaquet P, Enjalbert A: Mechanisms involved in the abnormal sensitivity of some prolactinomas to dopamine agonist therapies, Front Endocrinol 1994:14:95-105.
38. Caccavelli L, Feron F, Morange I, Rouet E, Benarous R, Dcwailly D, Jaquet P, Kordon C, Enjalbert A: Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas, Neuroendocrinology 1994;60:314-322.
39. Dal Toso R, Sommer B, Ewcrt M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg H: The dopamine D2 receptor: Two molecular forms generated by alternative splicing, EMBO J 1989:8:4025-4034.
40. Montmayeur JP, Borrelli E: Transcription mediated by cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptor, Proc Natl Acad Sci USA 1991:88: 3135-3139.
41. Audinot V, Rasolonjanahary R, Giros B, Martres MP, Sokoloff P, Schwartz JC, Kordon C, Enjalbcrt A: Couplage différentiel à la plios-pholipase C des deux isoformes du récepteur dopaminergique D2 transfcctées dans la lignée GH4CI, Ann Endocrinol I991;52:17N.
42. A receptor gene, J Ncurochcm 1991:56:1024-1029.
43. A receptor gene: Sequence homology with the rat and human genes and expression of alternative transcripts, J Ncurochcm 1991;57:795-801.
44. Friedman E, Adams EF, Log A, Gcjman PV, Carson E, Larson C, De Marco L, Wermcr S, Fahlbusch R, Nordenskjold M: Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors, J Clin Endocrinol Metab 1994;78:568-574.
45. Collu R, Bouvier C, Lagace G, Unson CG, Milligan G, Goldsmith P, Spiegel AM: Selective deficiency of guanine nucleotide-binding protein Go in two dopamine-resistant pituitary tumors, Endocrinology 1988:1222:1 176-1178.
46. Bouvier C, Forget H, Lagacé G, Drews R, Sin-nett D, Labuda D, Colu R: G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors, Mol Cell Endocrinol 1991:78: 33-44.
47. Caccavclli L, Morange I, Dewailly D, Kordon C, Jaquet P, Enjalbcrt A: Alteration of Ga subunits mRNAs levels in bromocriptine resistant prolactinomas, J Neuroendocrinol 1996:8: 737-746.
48. Tang WJ, Gilman AG: Adcnylyl cyclase, Cell 1992;70:869-872.
49. Andersen B, Rosenfeld MG: Pit-1 determines cell-types during development of the anterior pituitarv gland, J Biol Chem 1994:269:29335-29338.
50. Mangalan HJ, Albert VR, Ingraham H, Kapi-loff M, Wilson L, Nelson C, Elsholtz H, Roscn-feld MG: A pituitary POU domain protein, Pit-I, activates both growth hormone and prolactin promoters transcriptionally, Genes Dev 1989: 3:946-958.
51. Castrillo J-L, Theill LF, Karin M: Function of the homeodomain protein GHF1 in pituitary cell proliferation, Scicnce 1991:253:197-199.
52. Elsholtz FIP, Lew AM, Albert PR, Sundmark VC: Inhibitory control of prolactin and Pit-1 gene promoters by dopamine, J Biol Chcm 1991;266:22919-22925.
53. Lew AM, Yao H, Elsholtz HP: Gia2 and Goa-mediated signaling in the Pit-1-dependant inhibition of the prolactin gene promoter, J Biol Chem 1994:269:12007-12013.
54. Pellegrini I, Barlicr A, Gunz G, Figarella-Bran-ger D, Grisoli F, Enjalbcrt A, Jaquet P: Pit-1 gene expression in the human pituitary' and pituitary adenomas, J Clin Endocrinol Metab 1994:79:189-196.
55. Pellegrini I, Jaquet P: Pit-1 in pituitary tumors; in Melmed S (ed): Oncogenesis and Molecular Biology of Pituitary Tumors, Front Horm Res, Basel, Kargcr, 1996, vol 20, pp 41-53.
56. Pcllegrini-Bouiller I, Morange-Ramos I, Barlicr A, Gunz G, Enjalbcrt A, Jaquet P: Pit-1 gene expression in human pituitary adenomas, Horm Res 1997;47:251-258.
57. Lin C, Lin SC, Chang CP, Rosenfeld MG: Pit-1 dependent expression of the rcccptor for growth hormone releasing factor mediates pituitary cell growth, Nature 1992:360:765-767.
58. Hauser F, Meyerhof W, Wulscn I, Schonrock C, Richter D: Sequence analysis of the promoter region of the rat somatostatin rcccptor sub-type I gene, FEBS Lett 1994;345:225-228.
59. Valdcnaire O, Vernier P, Maus M, Dumas Milne Edwards JB, Mallet J: Transcription of the rat dopamine-D2-receptor gene from two promoters, Eur J Biochem 1994;220:577-584.
60. Minowa T, Minowa MT, Mouradian MM: Analysis of the promoter region of the rat D2 dopamine receptor gene, Biochemistry 1992: 31:8389-8396.
61. Rhodes SJ, Chen R, Dimattia GE, Scully KM, Kalla KA, Lin SC, Yu VC, Rosenfeld MG: A tissue-specific enhancer confers Pit-l-depen-dant morphogen inducibility and autorcgula-tion on the Pit-1 gene, Genes Dev 1993;7:913-932.